Skip to main content
Premium Trial:

Request an Annual Quote

VA, Polymedco Ink Deal for Colorectal Cancer Testing

NEW YORK (GenomeWeb News) – Polymedco announced today that two of its colorectal cancer screening products will now be available through the US Department of Veterans Affairs (VA) healthcare system.

Under the terms of the five-year contract, VA patients will have access to Eiken Chemical's OC-Light S manual fecal immunochemical test (FIT), as well as Epigenomics' Epi proColon colorectal cancer screen. Polymedco is the US distributor for the FIT and co-markets Epi proColon under a 2013 agreement with Epigenomics.

Additional terms of the contract were not disclosed.

Polymedco's OC-Auto automated FIT system is already available at VA facilities under an existing arrangement.

"We are excited to continue our relationship with the [VA] and pleased to be able to offer them our complete offering of colorectal cancer screening tools," Polymedco President Drew Cervasio said in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.